Schlumberger NV
NYSE:SLB
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
36.83
55.22
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Schlumberger NV
Wall Street
Price Targets
SLB Price Targets Summary
Schlumberger NV
According to Wall Street analysts, the average 1-year price target for
SLB
is 58.57 USD
with a low forecast of 49.49 USD and a high forecast of 68.25 USD.
SLB Last Price Targets
Schlumberger NV
The latest public price target was made on Oct 21, 2024 by
David Anderson
from
Barclays
,
who expects
SLB
stock to
rise by 66%
over the next 12 months.
You can read more about this price target by viewing
the article on Benzinga.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David Anderson
Barclays
|
61
USD
Upside 66% |
2 months ago
Oct 21, 2024
|
These Analysts Slash Their Forecasts On Schlumberger Following Q3 Earnings
Benzinga
|
Stephen Gengaro
Stifel Nicolaus
|
60
USD
Upside 63% |
2 months ago
Oct 21, 2024
|
SLB (SLB) PT Lowered to $60 at Stifel
StreetInsider
|
Neil Mehta
Goldman Sachs
|
52
USD
Upside 41% |
2 months ago
Oct 21, 2024
|
Goldman Sachs Reiterates Conviction Buy Rating on SLB (SLB)
StreetInsider
|
Bascome Majors
Susquehanna
|
56
USD
Upside 52% |
2 months ago
Oct 21, 2024
|
SLB (SLB) PT Lowered to $56 at Susquehanna
StreetInsider
|
Scott Gruber
Citigroup
|
54
USD
Upside 47% |
2 months ago
Oct 21, 2024
|
SLB (SLB) PT Lowered to $54 at Citi
StreetInsider
|
James Rollyson
Raymond James
|
57
USD
Upside 55% |
2 months ago
Oct 21, 2024
|
SLB (SLB) PT Lowered to $57 at Raymond James
StreetInsider
|
Lloyd Byrne
Jefferies
|
68
USD
Upside 85% |
2 months ago
Oct 2, 2024
|
SLB price target lowered to $68 from $73 at Jefferies
TheFly
|
Stewart Glickman
CFRA
|
42
USD
Upside 14% |
3 months ago
Sep 10, 2024
|
CFRA Downgrades SLB (SLB) to Hold
StreetInsider
|
|
Stephen Gengaro
Stifel Nicolaus
|
65
USD
Upside 76% |
5 months ago
Jul 22, 2024
|
SLB price target raised to $65 from $64 at Stifel
TheFly
|
James West
Evercore ISI
|
74
USD
Upside 101% |
5 months ago
Jul 22, 2024
|
SLB price target raised to $74 from $73 at Evercore ISI
TheFly
|
Mark Miller
RBC Capital
|
160
USD
Upside 334% |
5 months ago
Jul 15, 2024
|
Apple To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga
|
|
Keith Mackey
RBC Capital
|
69
USD
Upside 87% |
8 months ago
Apr 3, 2024
|
SLB (SLB) PT Raised to $69 at RBC Capital
StreetInsider
|
|
Guillaume Delaby
Societe Generale
|
81
USD
Upside 120% |
1 year ago
Dec 22, 2023
|
SLB , EOG Resources And Other Energy Stocks From Wall Street's Most Accurate Analysts
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SLB's stock price target?
Price Target
58.57
USD
According to Wall Street analysts, the average 1-year price target for
SLB
is 58.57 USD
with a low forecast of 49.49 USD and a high forecast of 68.25 USD.
What is Schlumberger NV's Revenue forecast?
Projected CAGR
5%
For the last 8 years the
compound annual growth rate for
Schlumberger NV's revenue is
-1%.
The projected
CAGR
for the next 4 years is
5%.
What is Schlumberger NV's Operating Income forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Schlumberger NV's operating income is
0%.
The projected
CAGR
for the next 4 years is
7%.
What is Schlumberger NV's Net Income forecast?
Projected CAGR
8%
For the last 8 years the
compound annual growth rate for
Schlumberger NV's net income is
9%.
The projected
CAGR
for the next 4 years is
8%.
You don't have any saved screeners yet
